Normal view MARC view ISBD view

[Antibodies to Yersinia enterocolitica and Proteus mirabilis in blood sera of rheumatoid arthritis patients]. [electronic resource]

By:

Maslova, I I

Contributor(s):

Producer: 20050311Description: 71-2 p. digitalISSN:

0372-9311

Subject(s):

In: Zhurnal mikrobiologii, epidemiologii i immunobiologii no. 4

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Comparative Study; Journal Article

There are no comments on this title.

to post a comment.

Back to results

2221 Antiretroviral chemotherapy.
by Saag, M S
2222 Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis.
by Shim, J Y
2223 Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results.
by Manosuthi, Weerawat
2224 [Ensuring high adherence. Clever combination assures therapeutic success].
2225 Discovery of olodaterol, a novel inhaled beta2-adrenoceptor agonist with a 24 h bronchodilatory efficacy.
by Bouyssou, Thierry
2226 Analgesic and antiinflammatory effects of cannabinoid receptor agonists in a rat model of neuropathic pain.
by Leichsenring, Anna
2227 Bayesian network analyses of resistance pathways against efavirenz and nevirapine.
by Deforche, Koen
2228 [The effect of the activation of cannabinoid receptor on the proliferation and apoptosis of hepatoma HepG2 cells].
by Wang, Ying
2229 Development of [F-18]fluorine-substituted Tanaproget as a progesterone receptor imaging agent for positron emission tomography.
by Lee, Jae Hak
2230 Orosomucoid (alpha1-acid glycoprotein) plasma concentration and genetic variants: effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation.
by Colombo, Sara
2231 The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin.
by Patwardhan, Amol M
2232 Efavirenz-induced neurological symptoms in rare homozygote CYP2B6 *2/*2 (C64T).
by Usami, Osamu
2233 Development of a new methodology for screening of human immunodeficiency virus type 1 microbicides based on real-time PCR quantification.
by Aguiar, Renato S
2234 Cannabinoid and opioid modulation of social play behavior in adolescent rats: differential behavioral mechanisms.
by Trezza, Viviana
2235 Anti-HIV agents. A second study confirms fat loss issues with efavirenz.
2236 [Structural and functional features of the rats' prefrontal cortex following 14-day suspension].
by Romanova, G A
2237 Changes in cortical thickness in the frontal lobes in schizophrenia are a result of thinning of pyramidal cell layers.
by Williams, M R
2238 Target-based screen against a periplasmic serine protease that regulates intrabacterial pH homeostasis in Mycobacterium tuberculosis.
by Zhao, Nan
2239 Effects of WIN 55,212-2 (a synthetic cannabinoid CB1 and CB2 receptor agonist) on the anticonvulsant activity of various novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice.
by Florek-Luszczki, Magdalena
2240 Depolarization of mitochondrial membrane potential is the initial event in non-nucleoside reverse transcriptase inhibitor efavirenz induced cytotoxicity.
by Ganta, Krishna Kumar